antipsychotics Flashcards
tricyclic antidepressant pharm action
mood elevating agents do not act as stimulants of CNS.
Only after a period of 2-3 weeks of chronic dosing will a therapeutic benefit emerge.
the precise mechanism responsible for the antidepressant action of the TCA is unknown
TCA theory of action
inhibition of norepi neuronal uptake
time dependent changes in beta adrenergic function parallel the delayed onset of clinical efficacy
mild effect on 5-HT central serotonin receptor sensitivity
TCA pharmacokinetics
well absorbed by GI tract large volume of distribution half lives range from 8-89 hours most require once a day dosing inactivation through oxidative metabolism by hepatic microsomal enzymes
TCA adverse effects
antimuscarinic efects (tachy, burry vision, constipated, dry mouth) sedation toxic delirium seizures weight gain involuntary movements neuroleptic malignant syndrome
TCA
weak alpha adrenergic antagonists, most common CV effects are ortostatic hypotension and tachy, sedation is thought to be mediated through antagonist properties at the apha 1 adrenoreceptor and H1 histaminergic receptor sites in the brain
lowers seizure threshold
CNS toxicity presents as a delirium with affective, cognitive, motor, and psych symptoms
overdose is frequently fatal with unresolvable arrhythmia’s
Selective Serotonin Re-uptake Inhibitors
produce therapeutic action through an ability to modulat serotonin neurotransmission in the brain
long cascade of events causes poentiation of serotonin neurotransmission at central synaptic sites.
SSRI pharm and kinetics
onset is the same as TCA
anticholinergic and cV side effects were not present in SSRI
side effects tolerated better:
GI effects- nausea and diarrhea
CNS stimulation- insomnia and anxiety
sexual dysfunction- aorgasmia and delayed ejaculation
weightloss
SSRI warnings
caution in combo with other antidepressants, benzos, neuroleptics, carbamepazine, and blood levels increase
elimination half life of fluoxetine
2-3 days
SSRI absorption dependent on food?
NO
Monoamine Oxidase Inhibitors (MAOI)
developed from iproniazid, a drug used to combat TB, patients noted to be happier while on med.
Reserved for atypical depression unresponsive to TCAs or SSRIs and depression resistant to ECT
MAOI mechanism of action
monoamine oxidase exists on the body as A and B
transmiter amines, such as norepi, are preferrably metabolized by MAO-A in brain tissue
MAO-B is involved in the catabolism of dopamine
drugs inhibit both A and B, but A is where therapeutic effect occurs
MAOI changes and side effects
adaptive effects occur in 2-3 weeks
side effects:
occasion with long term therapy, particulary for those who are slow acetylators
non hydrazine derivatives have low hepatotoxicity risk
CV effects- occur with ingestion of certain foods, low tyrosine diet, cheese beer and wine
tremors
ejaculatory delay
orthostaic hypotension
hyperpyrexia with meperidine dextromethorphan and TCA
trazadone
desyrel
less toxic and faster acting
anxiolytic properties acts at both seratonin and norepi sites in brain
common side effects are sedation dizziness hypotension and nausea
bupropion
wellbutrin and zyban
MOA unknown
free of muscarinic side effects
CNS stimulation with insomnia and nervousness
contraindicated in seizures or head trauma
lithium
effective 60-80% of BOD patients
mood stabilizing agent
replaces sodium at certain active sites
selective to CNS non selective excitatory tissues (CV)
Manic Depressive on lithium
adverse reactions are associated directly with therapeutic levels
narrow window (0.5-1.5mEq/L) necessitates frequent monitoring
toxicity presents as nausea, diarrhea, vomiting, abd pain, polyuria, sedation and mild tremor
many become hypothyroid after long term use
antipsychotic MOA
block synaptic actions of dopamine in the brain
the antagonism of dopamine in the medolimbic-mesocortical system is thought to be the basis of the therapeutic actions of the antipsychotic drugs, while antagonism of the nigrostriatal system in the major factor in the extrapyramidal side effects seen with antipsychotics
antipsychotic side effects
sedation- common with all antipsychotics, activate histamine receptors, given at bedtime
extrapyramidal effects- acute dystonia, akathisia, parkinsonism
antipsychotics extrapyramidal effects
actute dystonia in 5% of cases- treated centrally acting muscarinic agent (cogentin)
akathisia- unresponsive to cogentin- treated with benzos or beta blockers
tardive dyskenesia is a late occuring and usually an irreversabe phenomenon
neuroleptic malignant syndrome- fever, diffuse muscle rigidity, severe EPS, autonomic dysfunction (elev BP &HR)